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Abstract
Background: The pathophysiology of non-specific arm pain (NSAP) is unclear and the diagnosis
is made by excluding other specific upper limb pathologies, such as lateral epicondylitis or cervical
radiculopathy. The purpose of this study was to determine: (i) if the quantitative parameters related
to motor unit potential morphology and/or motor unit firing patterns derived from
electromyographic (EMG) signals detected from an affected muscle of patients with NSAP are
different from those detected in the same muscle of individuals with lateral epicondylitis (LE) and/
or control subjects and (ii) if the quantitative EMG parameters suggest that the underlying
pathophysiology in NSAP is either myopathic or neuropathic in nature.
Methods: Sixteen subjects with NSAP, 11 subjects with LE, eight subjects deemed to be at-risk
for developing a repetitive strain injury, and 37 control subjects participated. A quantitative
electromyography evaluation was completed using decomposition-based quantitative
electromyography (DQEMG). Needle- and surface-detected EMG signals were collected during
low-level isometric contractions of the extensor carpi radialis brevis (ECRB) muscle. DQEMG was
used to extract needle-detected motor unit potential trains (MUPTs), and needle-detected motor
unit potential (MUP) and surface detected motor unit potential (SMUP) morphology and motor
unit (MU) firing rates were compared among the four groups using one-way analysis of variance
(ANOVA). Post hoc analyses were performed using Tukey's pairwise comparisons.
Results: Significant group differences were found for all MUP variables and for MU firing rate (p <
0.006). The post-hoc analyses revealed that patients with NSAP had smaller MUP amplitude and
SMUP amplitude and area compared to the control and LE groups (p < 0.006). MUP duration and
AAR values were significantly larger in the NSAP, LE and at-risk groups compared to the control
group (p < 0.006); while MUP amplitude, duration and AAR values were smaller in the NSAP
compared to the LE group. SMUP duration was significantly shorter in the NSAP group compared
to the control group (p < 0.006). NSAP, LE and at-risk subjects had lower mean MU firing rates
than the control subjects (p < 0.006).
Conclusion: The size-related parameters suggest that the NSAP group had significantly smaller
MUPs and SMUPs than the control and LE subjects. Smaller MUPs and SMUPs may be indicative of
muscle fiber atrophy and/or loss. A prospective study is needed to confirm any causal relationship
between smaller MUPs and SMUPs and NSAP as found in this work.
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Background
Long-standing static contractions or repetitive work, such
as that performed in computer and assembly line environ-
ments, can lead to chronic muscle pain [1-3]. The wrist
extensor muscles have been implicated in a condition
called non-specific arm pain (NSAP) or work-related
upper limb disorder, which, as the names suggest, has an
unknown pathophysiology. Patients with NSAP complain
of diffuse forearm pain during and after tasks that require
repetitive wrist motion, and they have muscle pain and
tenderness on palpation that is not consistent with lateral
epicondylitis (LE), a known tendinopathy resulting from
repetitive wrist extension. The similarity between LE and
NSAP is that the pain radiates down the forearm and can
be replicated during resisted movements of the extensor
muscles of the wrist during work. In NSAP, the signs and
symptoms include diffuse pain in the forearm after aggra-
vating activities, muscle tenderness to palpation, reduced
grip strength, and functional loss [4]. A diagnosis of NSAP
is made when there is an absence of objective clinical
signs associated with known upper limb disorders, such as
medial or lateral epicondylitis, deQuervain's tendonitis
and cervical radiculopathy [4]. Although there appears to
be agreement on the mechanical factors that lead to the
development of NSAP (i.e., repetitive movements and sus-
tained postures), there are conflicting views regarding the
underlying pathophysiology of this condition [5].
Because we do not know what structures are affected and
in what way, we cannot properly diagnose or treat this
form of repetitive strain injury.
Some authors believe that chronic pain conditions such as
NSAP and trapezius myalgia, are associated with damage
within the muscle [1,6-10], whereas others believe they
are caused by neuropathic changes [11-14]. Patients with
chronic trapezius myalgia related to static muscle loading
during assembly work have been the focus of several stud-
ies where biopsies of the descending portion of the trape-
zius muscle have been taken in an attempt to determine
the underlying pathophysiology. 'Ragged-red' fibers have
been identified in these samples, and researchers have
therefore suggested that the origin of this condition is
associated with mitochondrial damage to the Type I fibers
[1,6,8], however, these results have not been conclusive,
with similar damage noted in individuals who perform
similar tasks but who are pain free. Dennet et al, [10] took
specimens from the first dorsal interosseous muscle of
keyboard operators with chronic overuse syndrome and,
when compared to healthy controls, found an increase in
the number of type I fibers, a lower number of type II fib-
ers, type II fiber hypertrophy, and mitochondrial changes.
Other researchers have found indications that chronic
muscle pain in the wrist flexor group (also referred to as
NSAP) may be neuropathic in nature [11,13]. In particu-
lar, Greening et al. speculate that NSAP affecting the wrist
flexor muscles is neuropathic in origin based on observed
changes in median nerve function [11,12,15].
In the current study, we have defined NSAP as a condition
affecting the wrist extensor muscles. These muscles are
innervated by the radial nerve, and therefore differential
diagnosis would include radial neuropathy, cervical radic-
ulopathy (C6) and muscle or tendon pathology. To our
knowledge, no evaluation methods, including electromy-
ographic (EMG) analysis techniques, have been used to
characterize muscles affected with NSAP. Changes in
motor unit morphology or firing pattern characteristics
may indicate the underlying pathophysiology associated
with the contractile deficits seen in this population.
Shape characteristics of motor unit potentials (MUPs)
provide insight into the underlying pathophysiology of
neuromuscular diseases [16-18]. In myopathies, classic
EMG findings are MUPs with reduced durations and
amplitudes due to loss of muscle fibers or fibrosis [17].
There is also increased complexity in the MUP waveforms,
which may be associated with atrophic or regenerating
muscle fibers [19], or with temporal dispersion among
muscle fiber potentials due to fiber diameter variations
[17]. In neuropathies, classic EMG findings include
increases in MUP duration and amplitude caused by
increased fiber number and density as orphaned muscle
fibers receive axonal sprouts from healthy axons. In this
case, the number of turns and phases may either be nor-
mal or increased [17].
In the present study, EMG signal decomposition-based
algorithms and quantitative MUP analysis techniques
were used to investigate the electrophysiological charac-
teristics of motor units (MUs) in healthy control subjects,
subjects deemed at risk for developing a repetitive strain
injury (RSI), and in individuals with LE and NSAP. The
purpose of this study was to determine: (i) if MU mor-
phology and firing pattern statistics as represented by
quantitative parameters of MUPs detected in an affected
muscle in individuals with NSAP are different from those
with LE and/or control subjects and (ii) if these quantita-
tive EMG parameters suggest that the underlying patho-
physiology in NSAP is either myopathic or neuropathic in
nature.
Methods
Subjects
A four-group cohort design was used in this study. Subject
recruitment occurred in the Kingston community by
advertisements posted in the local newspaper and posters
placed in local physiotherapy clinics and physicians'
offices. The advertisements asked for volunteers to partic-
ipate if they were between the ages of 18–60 years and
either (i) experienced elbow or forearm pain attributed toJournal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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their repetitive work/activities; (ii) worked in a repetitive
job where their colleagues were developing repetitive
strain injuries, but they had no symptoms themselves; or
(iii) did not work in a job that required repetitive hand
movement or perform activities (sports/arts) that were
repetitive (e.g., tennis/guitar) and had no current or previ-
ous upper limb injury or pain. Potential subjects under-
went a telephone screening interview to ensure that they
met the inclusion and exclusion criteria. Subjects were
excluded at the time of the interview if their symptoms
suggested that they might have a concurrent cervical
pathology; if their pain originated at the wrist, hand or
anterior forearm; or if they had a history of heart disease,
lung disease, neurological conditions or diabetes. The
study was approved by the Queen's University Health Sci-
ences Research Ethics Board (REH-183-03), and all sub-
jects provided written informed consent prior to
participation.
Experimental procedures
A clinical examination was performed for demographic
comparison among the groups who were exposed to
repetitive tasks (NSAP, LE, and at-risk subjects), to verify
correct group assignment and to verify that subjects had
no signs or symptoms of cervical radiculopathy and/or
other repetitive strain injury, such as carpal tunnel syn-
drome, deQuervain's tendonitis, or medial epicondylitis.
The screening examination consisted of a neurologic
examination of the upper extremities, including myotome
testing, dermatome (light touch, pin prick) testing, and
assessment of the deep tendon reflexes at the C5 to C8 lev-
els. Cervical spine range of motion was tested in sitting to
ensure that cervical movements did not reproduce the
forearm symptoms. The movements tested included flex-
ion, extension, lateral flexion, rotation, and combined
extension with lateral flexion. These movements were
held at the end of the available range of motion for 10 sec-
onds. Three repetitions of maximal handgrip strength
(Jamar Dynamomter, Sammons Preston Inc., Model #
5030J1; in position 2) and maximal pinch grip strength
(Baseline Evaluation Instruments, 60# mechanical pinch
gauge, model # 12-0201) were measured bilaterally with
the elbow flexed to 90 degrees, and with the wrist held in
neutral between flexion and extension, respectively.
A pressure algometer (model PTH-AF 2 Pain Diagnostic
and Treatment Corporation, Great Neck, NY 11021, USA)
was used to measure pain pressure threshold (PPTh) and
pain tolerance (PPtol). The device consists of an analog
force gauge fitted with a disc-shaped rubber tip (1 cm2).
The range of the gauge is 0–10 kg, with increment mark-
ings at 0.1 kg. Measurements were made at the nail bed of
the third digit (D3) and over all the bellies of the extensor
carpi radialis brevis (ECRB) muscle, the flexor carpi radia-
lis (FCR) muscle, the biceps brachii (BB) muscle and the
triceps brachii (TB) muscle. Pain tolerance scores (PPtol)
were normalized to the amount of pressure subjects could
withstand being applied to the nail bed on D3 of the
affected (or tested) limb.
Subjects were assigned to the LE group if their symptoms
were reproduced with resisted wrist extension in neutral,
passive wrist flexion with the elbow extended and if there
was pain on palpation of the lateral epicondyle. This
resisted wrist extension test was performed by stabilizing
the subject's forearm and then having him or her form a
fist and actively extend the wrist, keeping the elbow fully
extended. The examiner then attempted to force the wrist
into flexion. A reproduction of the subject's pain at the lat-
eral epicondyle during this contraction was considered a
positive test [20]. Subjects in the LE group experienced
pain on palpation of their lateral epicondyle. If pain
occurred during palpation of the ECRB muscle in subjects
in the LE group, it could not be reproduced by palpating
at a distance greater than 3 cm distal to the cubital crease
[4] since pain that is experienced more distally on the
wrist extensor group might be due to muscle tenderness
within the ECRB itself and not exclusively at the tendon.
Subjects who were assigned to the NSAP group experi-
enced pain on palpation of the ECRB muscle and com-
plained of forearm pain during wrist extension activities
performed at work or in their leisure activities, but resisted
wrist extension with elbow extension (as described above)
did not reproduce their signs and symptoms. Because our
goal was to characterize individuals with NSAP separately
from LE, we did not include any subjects who had signs or
symptoms that could be attributed to both LE and NSAP.
At-risk subjects had no pain on resisted wrist extension,
passive wrist flexion, or palpation of the lateral epi-
condyle or the ECRB muscle. Subjects who were assigned
to the asymptomatic at-risk group were required to have
no history of arm injury or pain and to work in a job that
demanded frequent or constant repetition of wrist exten-
sion, whereas the subjects in the control group did not
perform repetitive wrist motions at work or during their
leisure time.
Potential participants were excluded if resisted wrist flex-
ion, passive wrist extension and palpation of the medial
epicondyle reproduced symptoms, as these would indi-
cate the presence of a wrist flexor pathology. The upper
limb tension test (ULTT) with radial nerve bias (ULTT3)
was performed as described in Kleinrensink et al. [21].
These tests were used for sample description only, not to
rule out other pathology as they have questionable sensi-
tivity and specificity [21,22]. Two self-report outcome
measures, the Disability of the Arm, Shoulder and Hand
(DASH) questionnaire [23] and the Short Form-36 (SF-
36) questionnaire [24] were completed by the subjects.Journal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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The DASH questionnaire measures the disability in per-
sons with musculoskeletal disorders of the upper limb for
both descriptive and evaluative purposes [23,25]; the 30-
item questionnaire is scored out of 100, with a higher
score indicating a greater disability. The SF-36 uses a 0–
100 point scoring system that calculates health-related
quality of life with eight health dimensions: physical func-
tioning, role of physical functioning, bodily pain, general
health, vitality, social functioning, emotional role, and
mental health [24]. The control subjects did not undergo
the thorough clinical evaluation performed on the other
three groups since they were not in any pain and did not
perform repetitive activities.
A total of 80 potential participants came to the laboratory
for testing, and eight subjects who experience pain at their
elbow and or wrist extensors were excluded following the
clinical evaluation as they presented a mix of symptoms
that did not meet the inclusion criteria for either the NSAP
or LE group as outlined above, or that exhibited signs and
symptoms of both NSAP and LE.
Surface and intramuscular EMG recordings
All subjects underwent an electrophysiologic evaluation
of the ECRB muscle. The affected limb or the more seri-
ously affected limb (as determined by subjective com-
plaint) was used for electrophysiologic evaluation in the
LE and NSAP subjects. The dominant arm was selected in
control subjects; for at-risk subjects, the limb selected
(dominant/non-dominant) was matched to an LE or
NSAP subject of the same age and sex. For this evaluation,
subjects were seated in a straight-backed chair with the
elbow of the tested arm flexed to 90° and the forearm pro-
nated and resting on a custom-built table (Figure 1).
Adjustable straps attached to the bottom of the testing
table were passed through an opening and secured around
the dorsum of the hand to provide resistance during the
isometric extension contractions.
The DQEMG method and associated algorithms were
used, as described in detail elsewhere [18,26]. Prior to
electrode placement, the motor point of the ECRB muscle
of the test limb was identified as the area over the muscle
surface where the lowest possible electrical stimulus pro-
duced a minimal muscle twitch. The location of the motor
point in the ECRB muscle was approximately two centim-
eters distal to the cubital crease. Using the cathode portion
of a stimulating probe, with the train rate of the stimulator
set at 10 pps and the stimulation duration set at 1 ms [27],
the cathode was moved over the muscle belly until the
motor point region was determined. The skin over the
motor point, over the radial styloid process and over the
dorsum of the hand of the test limb was cleaned with rub-
bing alcohol prior to electrode placement. A surface Ag-
AgCl electrode (Kendall-LTP, Chicopee, Massachusetts)
was cut in half to measure 1 cm by 3 cm. The active elec-
trode was positioned over the motor point of the ECRB,
and the reference electrode was placed over the radial sty-
loid process to form a monopolar configuration. A full-
sized surface electrode (2 cm by 3 cm) was positioned on
the dorsum of the hand to act as the common reference.
Subjects were asked to perform a 3 second maximum vol-
untary contraction (MVC) of their wrist extensors with
verbal encouragement provided throughout. The peak
root mean square (RMS) value calculated over contiguous
one-second intervals of the surface EMG attained during
the MVC was determined. This highest computed value
represented the maximal voluntary effort (MVE) and all
subsequent contractions were expressed as a percentage of
the MVE and referred to as the %MVE-RMS.
A disposable concentric needle electrode (Model 740 38–
45/N; Ambu® Neuroline, Baltorpbakken, Ballerup, Den-
mark) was then inserted into the ECRB muscle using a dis-
tal to proximal approach so that the tip of the needle was
approximately 2 cm deep underneath the active surface
electrode. The needle position was adjusted until the aver-
age peak acceleration of the MUPs detected during a low-
level contraction (5–10% MVE) was above 30 kV/s2 [28].
Once a suitable needle position was found, the operator
stabilized the needle manually and then asked the subject
to hold a desired contraction force for 30 s. Subjects were
provided with a visual bar graph and a numerical value
that corresponded to their force output (%MVE-RMS) for
Experimental set-up and electrode position Figure 1
Experimental set-up and electrode position. The active 
electrode (A) was placed over the motor point of the ECRB 
muscle. The passive electrode was placed over the radial sty-
loid process (B). The common reference electrode was 
placed on the dorsum of the hand (C). A concentric needle 
electrode (D) was inserted in a distal to proximal direction 
parallel to the muscle fibers so that the tip of the needle was 
underneath the active electrode (A).Journal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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feedback. Following each contraction, the needle was
moved (medially, laterally, superficially and/or deeper)
so that MUPs generated by a representative pool of motor
units sampled from throughout the muscle would be
detected. Each subject performed repeated contractions
until at least 30 MUPTs were obtained. The contraction
force varied between 5–20% of MVE. A 2-minute rest
period was provided between contractions. AcquireEMG
algorithms running on a Neuroscan Comperio EMG sys-
tem (Neurosoft, Sterling, VA) were used to acquire the
needle and surface EMG data during 30 s intervals with a
sampling rate of 31250 and 3125 Hz respectively. The
needle- and surface-detected signals were bandpass fil-
tered from 10 Hz to 10 kHz and 5 Hz to 1 kHz respec-
tively.
Data reduction and analysis
After data collection, the MUPTs were evaluated through
visual inspection. The acceptability of each MUPT, each
needle-detected MUP, and each surface-detected MUP
was based on previously reported criteria [26]. Briefly, an
acceptable train had at least 50 MUPs and a consistent fir-
ing rate plot in the physiological range (8 Hz–30 Hz), as
well as an inter-discharge interval (IDI) histogram with a
Gaussian-shaped main peak and a coefficient of variation
of ≤ 0.3 [29]. Any MUPTs that did not meet all of these cri-
teria were excluded from analysis.
Markers indicating the onset, negative peak, positive peak
and end of the MUP waveforms, and markers indicating
the onset, negative peak onset, negative peak, positive
peak, and end of the SMUP waveforms were automatically
determined by the software; they were visually inspected
for accuracy and manually repositioned if incorrectly
placed.
Mean MU firing rate, and MUP and SMUP morphological
parameters were measured and used as dependent varia-
bles in the data analysis. The MUP parameters included
peak-to-peak amplitude, duration, number of phases, and
area-to-amplitude ratio (AAR). The SMUP parameters
included peak-to-peak amplitude, area, and duration.
Statistical Analysis
Descriptive data are reported as means ± standard devia-
tions, and were analyzed using MINITAB® Statistical Soft-
ware (v.14). Differences between group means for the
demographic data (age, weight, height, disease duration,
and wrist extensor MVC force) were tested using one-way
analysis of variance (ANOVA) models. Demographic var-
iables from the clinical evaluation were compared using
one-way ANOVAs. The alpha level was set at 0.05 for all
tests.
MUP and SMUP morphology and mean MU firing rates
were compared among the four groups using one-way
ANOVAs. The  -level was adjusted to account for multiple
comparisons (   = 0.05/8) and was therefore set at    =
0.006. Post hoc analyses were performed using Tukey's
pairwise comparisons.
Results
Demographic data
A total of 72 subjects participated: sixteen subjects with
NSAP (7 men, 9 women), 11 subjects with LE (6 men, 5
women), 8 subjects at-risk (2 men, 6 women), and 37
control subjects (15 men, 22 women). The demographic
data of the four groups are listed in Table 1. The subjects
with NSAP had a mean symptom duration of 27(± 32)
months, and the subjects with LE had a mean symptom
duration of 39(± 31) months. There was no difference in
this duration between these groups (p = 0.33). The control
subjects were significantly younger in age and stronger in
MVC wrist extensor strength than the other three groups
(p < 0.05).
Clinical evaluation outcomes
The clinical evaluation measures from the at-risk, NSAP
and LE group are shown in Table 2. The NSAP group had
significantly higher DASH scores for all three modules
than the at-risk subjects (p < 0.05). The LE subjects had
significantly higher DASH scores for the disability module
and sport/art module than the at-risk group (p < 0.05),
but not the work module (p > 0.05). No significant differ-
ences in reported disability scores were found between the
NSAP and LE groups (p > 0.05).
Significant differences in four of the eight dimensions of
the SF-36 were found between the three groups as shown
in Table 2. The post hoc analysis revealed no significant
differences between the NSAP and LE groups; however,
significant differences were identified between the LE and
at-risk individuals for the physical functioning, role phys-
ical functioning, bodily pain, and vitality dimensions (p <
0.05), where the individuals with LE scored significantly
lower. The post hoc analysis also revealed that the NSAP
group scored significantly lower than the at-risk subjects
for the role of physical functioning and bodily pain
dimensions (p < 0.05) and tended to score lower for the
physical functioning dimension (p = 0.078).
The ULTT3 with radial bias revealed five out of 11 subjects
had a positive test in the LE group, whereas none of the
NSAP subjects or at-risk subjects had a positive test. The
normalized score for PPtol on the ECRB and triceps bra-
chii (TB) muscle was found to be significantly lower in the
NSAP subjects compared to the at-risk subjects (p < 0.05).
All other PPtol scores were not found to be significantly
different among the groups (p > 0.05). Handgrip strength
and pinch-grip strength of the tested limb were not signif-
icantly different among the groups (p > 0.05).Journal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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MUP morphology and mean MU firing rates
Significant group differences were found for all MUP var-
iables and for mean MU firing rate (p < 0.006) as identi-
fied in Table 3. Post hoc analyses revealed that the NSAP
group had significantly smaller MUP amplitudes than the
control and LE groups (p < 0.006). The at-risk subjects had
MUP amplitudes that were not significantly different from
any other group (p > 0.006). The control group had signif-
icantly shorter duration measures than the other groups,
and the NSAP group had significantly smaller MUP dura-
tions than the LE and at-risk groups (p < 0.006). The NSAP
group demonstrated greater number of phases than the
control group (p < 0.006). Post hoc analysis of MUP AAR
revealed that: i) AAR in the NSAP, LE and at-risk groups
were all larger than the AAR of the control group and ii)
the LE group had significantly larger MUP AAR than the
NSAP and at-risk group (p < 0.006). Post hoc analysis of
mean MU firing rate revealed significantly higher firing
rates in the control group than the NSAP and LE groups (p
< 0.006).
SMUP morphology
Significant group differences were found for all SMUP var-
iables (p < 0.006), as identified in Table 3. The NSAP
group had significantly lower SMUP amplitudes and areas
compared to the control and LE groups (p < 0.006), and
the at-risk group showed significantly lower SMUP ampli-
tudes and areas compared to the control group (p  <
0.006). The NSAP group had significantly shorter SMUP
duration than the control and at-risk groups (p < 0.006).
Discussion
Patients with NSAP present with inconclusive neurologi-
cal and musculoskeletal system examinations even
though they complain of debilitating pain during the per-
formance of their work and activities of daily living. For
this reason, the goals of this study were: i) to determine if
quantitative EMG could be used to detect differences in
neuromuscular physiology in a group of individuals with
NSAP as compared to healthy subjects and ii) if such dif-
ferences were identified, whether this condition was myo-
pathic or neuropathic in nature. It is not until one knows
what structures are involved that one can properly diag-
nose, treat and measure treatment effectiveness in this
form of repetitive strain injury.
In the current study, individuals with NSAP and LE had
higher disability scores and a decreased physical function
when compared to the asymptomatic subjects using the
DASH and SF-36 questionnaires. The DQEMG results
identified significant group differences for all MUP varia-
bles and MU firing rate (p < 0.006). Patients with NSAP
had smaller MUP and SMUP amplitudes compared to the
control and LE groups (p < 0.006). MUP durations were
significantly longer in the NSAP, LE and at-risk groups
compared to the control group (p < 0.006), but signifi-
cantly shorter in the NSAP group compared to the at-risk
and LE groups; SMUP duration was significantly shorter
in the NSAP group compared to the control and at-risk
groups (p < 0.006). NSAP and LE subjects had lower mean
MU firing rates than the control subjects (p < 0.006).
With respect to the number of subjects used in each of the
groups, having a sample size of eight for the asympto-
matic at-risk group was small and lower than desired;
nonetheless, there was sufficient statistical power to detect
differences in many of the measures studied. Ideally, we
would have had a larger sample of individuals at-risk (n =
20), but our recruitment efforts were limited particularly
by our exclusion criteria that required individuals at risk
of RSI to not have had any previous upper extremity signs
or symptoms Our small sample size for the at-risk group
was, however, in line with the literature. Greening et al.
[13] found differences in longitudinal nerve movement
when only seven control subjects were compared to eight
subjects with NSAP (wrist flexor group), and Boe et al.,
[30] found differences in motor unit number estimates
(MUNE) comparing only 10 healthy subjects to nine
patients with amyotrophic lateral sclerosis (ALS). In a
recent study that assessed fine motor control in patients
with occupation-related lateral epicondylitis, the 28 sub-
jects who participated had a mean age of 42.0 ± 6.4 years
[31], which is similar to the at-risk, LE and NSAP groups
(age = 44.75 ± 13.48, 50.25 ± 9.21 and 46.6 ± 10.7 years,
respectively) in the current study. Our sample is consist-
ent with the repetitive strain injury literature with respect
to sample size and age.
The clinical outcome measures revealed that there was
increased ECRB muscle sensitivity (PPtol), increased disa-
bility (DASH), and decreased health-related quality of life
Table 1: Demographic data of the tested limb for the at-risk (n = 8), NSAP (n = 16), LE (n = 11) and control group (n = 37).
At-risk
Mean ± SD
NSAP
Mean ± SD
LE
Mean ± SD
Control
Mean ± SD
Height (cm) 169.76 ± 9.20 165.58 ± 8.06 168.33 ± 7.63 171.62 ± 8.38
Weight (lbs) 148.38 ± 23.75 158.06 ± 29.74 165.91 ± 31.65 148.92 ± 24.17
Age (years) 44.75 ± 13.48** 50.25 ± 9.21** 46.55 ± 10.65** 27.09 ± 5.00*
MVC (N) 105.2 ± 52.18** 126.81 ± 50.89** 137.79 ± 57.29** 194.46 ± 51.30*
Parameters marked with * are significantly different from the other groups parameters marked with ** (p < 0.05)Journal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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(SF-36) associated with NSAP as compared to individuals
at-risk, but that individuals with NSAP were no more sen-
sitive to pressure and no more disabled than individuals
with LE. The DASH questionnaire is scored out of 100,
with a higher score indicating a greater disability. The
DASH scores measured from our LE group (32.39 ±
15.10) were similar to those found in a previous study of
LE patients (33.0 ± 15.9) [32]. The analysis of health
dimensions from the SF-36 questionnaire revealed that
the pain NSAP and LE individuals experienced was related
Table 2: Clinical evaluation outcomes from the Disability of arm shoulder and hand (DASH) questionnaire, SF-36 eight domain scores, 
ULTT3 (number of positive tests) pain threshold scores (values in brackets are normalized to third nail bed; D3), grip and pinch-grip 
strength for the at-risk, NSAP and LE groups.
At-risk NSAP LE
n Mean ± SD n Mean ± SD n Mean ± SD
DASH
Disability score 8 0.66 ± 1.29* 16 23.83 ± 12.96** 11 32.39 ± 15.10**
Work module 8 0.00 ± 0.00* 15 35.22 ± 31.59** 11 28.98 ± 26.56
Sport/art module 4 0.00 ± 0.00* 9 68.06 ± 29.22** 7 56.3 ± 27.2**
SF-36
Physical functioning 8 97.50 ± 3.78* 15 82.00 ± 18.01** 11 75.45 ± 17.39**
Role physical 8 100.00 ± 0.0* 16 62.50 ± 38.76** 11 50.00 ± 41.83**
Bodily pain 8 88.50 ± 10.35* 16 57.38 ± 18.75** 11 47.36 ± 21.72**
General health 8 84.88 ± 5.51 16 73.12 ± 20.04 11 68.27 ± 20.65
Vitality 8 73.75 ± 11.88* 16 61.56 ± 18.86 11 53.18 ± 19.01**
Social functioning 8 98.44 ± 4.42 16 84.38 ± 17.38 11 77.27 ± 31.03
Emotional role 8 83.33 ± 30.86 16 83.33 ± 32.20 11 81.82 ± 27.34
Mental health 8 88.00 ± 9.32 16 76.50 ± 16.58 11 73.09 ± 16.88
ULLT3 (n positive) 8 0 16 0 11 5
Pain Threshold (kg/cm2)
D3 8 10.38 ± 5.87 16 12.87 ± 5.95 11 15.03 ± 6.23
ECRB 8 8.03 ± 4.82 (77%)* 16 5.78 ± 3.49 (45%)** 11 7.34 ± 4.16 (49%)
FCR 8 10.74 ± 6.73 (103%) 16 9.18 ± 5.06 (71%) 11 9.72 ± 4.86 (65%)
BB 8 8.48 ± 3.59 (82%) 16 9.08 ± 4.74 (71%) 11 10.65 ± 6.24 (71%)
TB 8 9.34 ± 4.72 (90%)* 16 8.28 ± 5.02 (64%)** 11 12.58 ± 6.72 (84%)
Grip strength (kg) 8 31.75 ± 5.56 16 33.95 ± 13.06 11 33.02 ± 12.53
Pinch-grip strength (kg) 8 7.39 ± 7.62 16 9.41 ± 3.89 11 11.14 ± 4.28
Parameters marked with * are significantly different from the other groups parameters marked with ** (p < 0.05)
Table 3: Mean MUP and SMUP morphology and mean MU firing rates across the four groups.
Control
n = 37
At-risk
n = 8
LE
n = 11
NSAP
n = 16
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Needle-detected MUPs
Amplitude (μV) 491.1 ± 300.7* 444.1 ± 233.4 519.0 ± 426.6† 420.9 ± 282.4**‡
Duration (ms) 7.64 ± 2.85* 9.76 ± 2.99**‡ 9.70 ± 3.16**‡ 8.36 ± 2.68**†
Number of Phases 2.55 ± 0.71* 2.72 ± 0.77 2.63 ± 0.81 2.74 ± 0.82**
AAR (ms) 1.27 ± 0.43* 1.43 ± 0.39**h 1.62 ± 0.59**†hh 1.34 ± 0.43**‡
Mean MU Firing rate (Hz) 14.98 ± 2.97* 14.73 ± 3.04 13.86 ± 2.71** 14.53 ± 2.68**
Surface-detected MUPs
Amplitude (mV) 113.73 ± 90.73* 91.28 ± 49.45** 111.14 ± 109.53† 65.75 ± 41.58**‡
Area (mVms) 593.9 ± 507.4* 424.4 ± 230.1** 502.7 ± 518.7† 273.7 ± 182.6**‡
Duration (ms) 19.76 ± 5.52* 19.69 ± 4.54† 19.21 ± 5.93 17.25 ± 5.21**‡
Parameters marked with * are significantly different from the other groups parameters marked with ** (p < 0.006)
Parameters marked with † are significantly different from the other groups parameters marked with ‡ (p < 0.006)
Parameters marked with h are significantly different from the other groups parameters marked with hh (p < 0.006)Journal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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to a decreased health-related quality of life. In a study that
examined physical and psychosocial workplace factors on
neck/shoulder pain with pressure tenderness in the mus-
cles of individuals performing highly repetitive, monoto-
nous work, all eight dimensions of the SF-36 quest
ionnaire were significantly reduced when compared to
individuals without pain [33].
It has been suggested that tender points within an affected
muscle are sites of local pathology, and they are believed
by some to be due to local muscle spasm or fibrosis
[34,35]. The physiological mechanisms underlying PPtol
changes have also been suggested to reflect muscle [36] or
nerve dysfunction [37,38]. Reduced PPtol has been
observed in medical secretaries [39], and automobile
assembly line workers [40,41]. The amount of pressure
that could be tolerated over the ECRB muscle was signifi-
cantly lower in our NSAP group compared to the at-risk
subjects. In LE, lower pain tolerance levels have been
observed in the ECRB muscle compared to the PPtol in
control subjects [42]. We did not find a significant reduc-
tion in the PPtol of our subjects with LE.
Using quantitative electromyography to study shape char-
acteristics of MUPs provide insight into the underlying
pathophysiology of neuromuscular diseases [16-18]. In
myopathies, MUPs have reduced durations and ampli-
tudes due to loss of muscle fibers or fibrosis [17], and
increased complexity in the MUP waveforms [17,19]. In
neuropathies, increases in MUP duration, amplitude,
number of turns and phases are caused by increased fiber
number and density from the reinnervation process [17].
The quantitative information used in the current analysis
included the amplitude, duration, area-to-amplitude ratio
(AAR), and number of phases of MUPs, as well as the
amplitude, area and duration of SMUPs and mean MU fir-
ing rate. In general, SMUP parameters have shown higher
reliability scores than needle-detected MUP parameters
[43], as they are less affected by the location of the detec-
tion surfaces [44]. The quantitative EMG analysis results
indicate that there were significant differences between
subjects with NSAP and individuals with LE, healthy con-
trol subjects or asymptomatic individuals exposed to sim-
ilar repetitive work tasks. To our knowledge, this is the
first study that has found measurable differences in elec-
trophysiological characteristics between individuals with
NSAP and healthy control subjects. The fact that differ-
ences in MUP morphology were present in a comparison
between muscles affected by NSAP and muscles affected
by LE suggests that these conditions are not a continuum
of a single pathophysiology. In fact, comparing the mor-
phology of the MUPs of the LE group to those of the NSAP
group (increased LE MUP amplitude and AAR and
increased LE SMUP amplitude, area and duration relative
to NSAP values) suggests that the motor units in the ECRB
muscles of the LE group subjects are larger than those of
the NSAP group, which in turn suggests that at least some
individuals in the LE group might have had neuropathic
changes in their affected muscle. This supports the clinical
belief that LE may be associated with cervical radiculopa-
thy [45]. Although we excluded individuals with signs or
symptoms of radiculopathy, quantitative EMG analysis
may be more sensitive than subjective and objective clin-
ical examination. Interestingly, the ULTT3 results were
only found positive in subjects in the LE group, and this
test is thought to detect compression or traction of the
nerve [22].
The MUP-based electrophysiological findings suggest that
NSAP may be myopathic in nature, since MUPs detected
in the affected muscles of this group were smaller (lower
amplitudes) and more complex (more phases) than
MUPs detected in the muscles of the control group and
shorter than MUPs detected in the muscles of the age-
matched at-risk and LE groups [17]. In addition, all of the
SMUP parameters were significantly smaller in the NSAP
group, further supporting the suggestion that NSAP may
be associated with changes within the muscle itself such as
a loss of muscle fibers, fibrosis [17], or atrophy. The obser-
vation that the morphological parameter values of the
MUPs and SMUPs for the at-risk group fall between those
of the NSAP group and those of the control group suggests
that repetitive work may cause morphological changes
within the ECRB muscle. These changes may predispose
individuals to developing painful muscles.
The sample recruited for the current study had signifi-
cantly younger control subjects than the other three
groups. This was related to the main criteria for fitting into
the asymptomatic control group, where individuals were
to be healthy and to not perform regular repetitive activi-
ties in their job or leisure activities; most of the control
subjects were therefore undergraduate or graduate stu-
dents who did not yet have a full-time occupation, and
who did not spend more than four hours per day perform-
ing computer keyboard work. This age gap is consistent
with another study where quantitative MUP analysis was
used to compare control subjects (27 ± 4 years) to individ-
uals with ALS (52 ± 12 years) [30]. However, with normal
aging, muscle atrophy occurs as a result of fiber loss and
the total number of fibers within a given muscle is
reduced. The surviving fibers often show evidence of fiber-
type grouping where denervation may have occurred [46].
McComas et al. [47], investigated the effects of aging on
the number of motor units in the thenar, extensor digito-
rum brevis and biceps brachii muscles, and they found
losses of motor units with increasing age. In the distal
muscles, the declines became statistically significant in the
60 to 79 year age group, and were even more evident in
the 80 to 98 year age group, whereas the numbers ofJournal of NeuroEngineering and Rehabilitation 2008, 5:34 http://www.jneuroengrehab.com/content/5/1/34
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motor units in the bicep brachii were well maintained in
all age groups. Our NSAP subjects were close to the 60-
year-old mark (50.25 ± 9.21); therefore the effects of aging
on their ECRB muscles should be considered. The age of
our at-risk and LE subjects was also higher than that of our
control subjects and similar to that of the NSAP group.
Therefore aging would likely have affected these three
groups similarly.
As an example of possible aging effects, consider that the
control group had significantly shorter MUP durations
and significantly smaller AAR values compared to the
other groups. The shorter MUP duration and smaller AAR
values found in the control group are not consistent with
our speculation that NSAP may be caused by a myopathic
process. Decreased MUP duration and reduced AAR val-
ues are important distinguishing features of needle-
detected MUPs in neuromuscular disease, and in myo-
pathic disease the MUPs are expected to be shorter in
duration and have smaller AAR values than in unaffected
muscles [48]. This discrepancy in our findings may be
related to the difficulty in reliably determining MUP onset
and end markers [44,49-52] and the consequences of this
on the MUP duration and AAR measures [43,49,51,52].
However, as individuals age, the durations and AAR val-
ues of their needle-detected MUPs increase [53,54]. This,
combined with the fact that the durations and AAR values
of the NSAP MUPs were shorter and smaller respectively
than those of the closer age-matched LE and at-risk
groups, strongly suggests that the discrepancy is more
likely related to the age difference between the control and
other groups.
Furthermore, although our NSAP subjects were not over
the age of 60 (where significant decreases in the number
of motor units within a distal muscle begins to be
observed [47]), they were close to the age of 60. As such,
the effects of the age of our NSAP group would be to
increase MUP amplitude [54] and to increase SMUP
amplitude and area [55]. Thus our findings of lower MUP
amplitude and lower SMUP amplitude and area in the
NSAP group relative to the control group are even more
strongly suggestive of myopathic changes as opposed to
motor unit loss (i.e., neuropathic changes) in the muscle
of the subjects in the NSAP group.
Future research investigating motor unit number estima-
tion (MUNE) through EMG as well as fiber type composi-
tion through histological studies in this patient
population would provide further insight into the patho-
physiology of NSAP.
The statistically significant reduction in firing rates seen in
the LE and NSAP groups relative to the control group may
not be clinically relevant, as the differences were very
small (Control group = 14.98 ± 2.97 Hz, LE group = 13.86
± 2.71 Hz, and NSAP group = 14.53 ± 2.68 Hz) and the
mean firing rates in all groups remained within a normal
range (5–20 pps for wrist extensor contractions between
5–20% of MVC [56]). The reduction in MU firing rates
observed may also be attributed to the age differences
between the groups [57].
Conclusion
All the detected MUP size-related parameters revealed that
the NSAP group had significantly smaller MUPs than the
control and LE subjects. Smaller MUPs are often associ-
ated with myopathic conditions and may be indicative of
fiber atrophy and/or loss within a motor unit. Evidence of
these same changes was found in the at-risk subjects,
whose amplitude measures were also smaller than the
control subjects, but not smaller than the subjects with
NSAP. As such, these findings may reflect the effects of
habitual use on muscle structure (all NSAP and at-risk
subjects had occupations that required repetitive low-level
contractions of the ECRB muscles) and not pathology.
The fact that the MUP and SMUP durations are not the
same for the at-risk and NSAP subjects provides evidence
that there may be muscle pathology in NSAP and that our
results do not simply reflect a training effect.
Interestingly, the group of subjects with LE actually
showed increases in MUP size relative to the control sub-
jects, suggesting that the neuromuscular changes seen in
individuals with NSAP are not the same as those seen in
individuals with LE. The larger MUPs in the LE group are
consistent with the clinical belief that patients with LE are
often thought to have cervical radiculopathy. A prospec-
tive study is needed to confirm any causal relationship
between smaller MUPs and SMUPs and NSAP as found in
this work.
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